LifeStance Health Group (LFST) Competitors

LifeStance Health Group logo
$7.84 -0.10 (-1.20%)
As of 03:03 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LFST vs. HIMS, GH, OPCH, RDNT, SHC, BTSG, SGRY, VCYT, CON, and PRVA

Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), Veracyte (VCYT), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

LifeStance Health Group vs.

LifeStance Health Group (NASDAQ:LFST) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Hims & Hers Health has lower revenue, but higher earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.06B2.88-$186.26M-$0.26-30.54
Hims & Hers Health$872M10.91-$23.55M$0.4499.01

Hims & Hers Health has a net margin of 8.19% compared to LifeStance Health Group's net margin of -7.90%. Hims & Hers Health's return on equity of 10.97% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group-7.90% -6.66% -4.51%
Hims & Hers Health 8.19%10.97%8.29%

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 6.6% of LifeStance Health Group shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

LifeStance Health Group presently has a consensus price target of $8.70, indicating a potential upside of 9.57%. Hims & Hers Health has a consensus price target of $25.13, indicating a potential downside of 42.31%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, research analysts plainly believe LifeStance Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Hims & Hers Health
2 Sell rating(s)
7 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.35

LifeStance Health Group has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500.

Hims & Hers Health received 30 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 39.05% of users gave Hims & Hers Health an outperform vote while only 26.19% of users gave LifeStance Health Group an outperform vote.

CompanyUnderperformOutperform
LifeStance Health GroupOutperform Votes
11
26.19%
Underperform Votes
31
73.81%
Hims & Hers HealthOutperform Votes
41
39.05%
Underperform Votes
64
60.95%

In the previous week, Hims & Hers Health had 38 more articles in the media than LifeStance Health Group. MarketBeat recorded 41 mentions for Hims & Hers Health and 3 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 1.22 beat Hims & Hers Health's score of 0.67 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
22 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

Hims & Hers Health beats LifeStance Health Group on 13 of the 18 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFST vs. The Competition

MetricLifeStance Health GroupHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$3.05B$982.18M$5.75B$9.12B
Dividend YieldN/A2.01%5.28%4.00%
P/E Ratio-30.5426.3462.3115.39
Price / Sales2.883.971,044.6173.78
Price / CashN/A25.3046.0638.87
Price / Book2.112.885.074.99
Net Income-$186.26M-$3.49M$113.48M$222.61M
7 Day Performance-2.58%0.27%-1.87%-0.88%
1 Month Performance2.72%2.27%3.24%2.62%
1 Year Performance13.59%138.97%20.95%17.59%

LifeStance Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFST
LifeStance Health Group
1.5663 of 5 stars
$7.85
-1.2%
$8.70
+10.9%
+19.6%$3.01B$1.06B-30.219,325Positive News
HIMS
Hims & Hers Health
3.357 of 5 stars
$44.70
+5.1%
$25.13
-43.8%
+341.4%$9.77B$872M101.601,046Insider Trade
GH
Guardant Health
3.8996 of 5 stars
$44.40
-0.2%
$42.63
-4.0%
+92.8%$5.49B$563.95M-10.471,779Short Interest ↓
Gap Down
OPCH
Option Care Health
4.5454 of 5 stars
$31.35
+1.2%
$32.25
+2.9%
-3.6%$5.34B$4.30B26.347,802Positive News
RDNT
RadNet
3.7521 of 5 stars
$62.35
-0.7%
$75.50
+21.1%
+63.9%$4.62B$1.62B-890.5910,288Short Interest ↑
Positive News
SHC
Sotera Health
3.423 of 5 stars
$13.87
+1.7%
$16.08
+16.0%
-15.9%$3.93B$1.05B55.483,000Positive News
BTSG
BrightSpring Health Services
2.7791 of 5 stars
$22.27
+0.7%
$19.42
-12.8%
+94.1%$3.88B$8.83B-85.6535,000
SGRY
Surgery Partners
3.254 of 5 stars
$25.58
-0.9%
$36.56
+42.9%
-23.6%$3.25B$2.99B-53.2913,500Insider Trade
VCYT
Veracyte
3.4828 of 5 stars
$41.93
+0.9%
$42.00
+0.2%
+60.2%$3.22B$425.33M-279.53790Analyst Upgrade
CON
Concentra Group Holdings Parent
N/A$22.67
-0.5%
$28.63
+26.3%
N/A$2.89B$1.84B0.0011,000Positive News
PRVA
Privia Health Group
2.3209 of 5 stars
$23.83
+5.9%
$24.88
+4.4%
+14.6%$2.86B$1.66B238.321,102

Related Companies and Tools


This page (NASDAQ:LFST) was last updated on 2/12/2025 by MarketBeat.com Staff
From Our Partners